$4.15 Billion is the total value of PFM Health Sciences, LP's 73 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 152.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HOT | Buy | STARWOOD HOTELS&RESORTS WRLD | $210,921,000 | +46.4% | 3,174,135 | +39.2% | 5.08% | +69.8% |
| A | Buy | AGILENT TECHNOLOGIES INC | $184,459,000 | +62.7% | 3,599,201 | +35.8% | 4.44% | +88.7% |
| DG | Buy | DOLLAR GEN CORP NEW | $173,025,000 | +47.0% | 3,064,559 | +31.3% | 4.17% | +70.5% |
| TWX | Buy | TIME WARNER INC | $137,335,000 | +89.3% | 2,086,848 | +66.3% | 3.31% | +119.5% |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $123,236,000 | -9.2% | 2,026,908 | +0.1% | 2.97% | +5.3% |
| BIDU | New | BAIDU INCspon adr rep a | $110,240,000 | – | 710,399 | +100.0% | 2.66% | – |
| ADBE | New | ADOBE SYS INC | $106,080,000 | – | 2,042,347 | +100.0% | 2.56% | – |
| CAM | Buy | CAMERON INTERNATIONAL CORP | $105,867,000 | +262.5% | 1,813,731 | +279.9% | 2.55% | +320.1% |
| WCRX | Buy | WARNER CHILCOTT PLC IRELAND | $104,075,000 | +47.0% | 4,538,824 | +27.6% | 2.51% | +70.4% |
| CRM | Buy | SALESFORCE COM INC | $90,000,000 | +272.1% | 1,733,775 | +173.7% | 2.17% | +331.9% |
| AMT | New | AMERICAN TOWER CORP NEW | $87,430,000 | – | 1,179,417 | +100.0% | 2.11% | – |
| MDCO | New | MEDICINES CO | $79,278,000 | – | 2,365,101 | +100.0% | 1.91% | – |
| REGN | Buy | REGENERON PHARMACEUTICALS | $76,003,000 | +519.4% | 242,922 | +345.2% | 1.83% | +618.0% |
| AMZN | Buy | AMAZON COM INC | $70,310,000 | +25.4% | 224,892 | +11.4% | 1.69% | +45.5% |
| LOW | Buy | LOWES COS INC | $67,520,000 | +18.3% | 1,418,185 | +1.6% | 1.63% | +37.1% |
| TIBX | Buy | TIBCO SOFTWARE INC | $57,980,000 | +75.8% | 2,265,712 | +47.0% | 1.40% | +103.9% |
| PCP | New | PRECISION CASTPARTS CORP | $52,735,000 | – | 232,067 | +100.0% | 1.27% | – |
| AAPL | New | APPLE INC | $51,451,000 | – | 107,920 | +100.0% | 1.24% | – |
| SCHW | New | SCHWAB CHARLES CORP NEW | $44,930,000 | – | 2,125,377 | +100.0% | 1.08% | – |
| TEX | New | TEREX CORP NEW | $42,484,000 | – | 1,264,391 | +100.0% | 1.02% | – |
| VIPS | New | VIPSHOP HLDGS LTDsponsored adr | $40,052,000 | – | 705,149 | +100.0% | 0.96% | – |
| JCI | New | JOHNSON CTLS INC | $39,553,000 | – | 953,085 | +100.0% | 0.95% | – |
| Buy | DENDREON CORPnote 2.875% 1/1 | $38,924,000 | +40.3% | 60,818,000 | +65.5% | 0.94% | +62.8% | |
| TDC | New | TERADATA CORP DEL | $37,374,000 | – | 674,137 | +100.0% | 0.90% | – |
| AUXL | New | AUXILIUM PHARMACEUTICALS INC | $23,861,000 | – | 1,311,017 | +100.0% | 0.58% | – |
| YELP | New | YELP INCcl a | $23,057,000 | – | 348,393 | +100.0% | 0.56% | – |
| THC | New | TENET HEALTHCARE CORP | $18,977,000 | – | 460,727 | +100.0% | 0.46% | – |
| MRK | Buy | MERCK & CO INC NEW | $18,537,000 | +781.9% | 389,358 | +760.3% | 0.45% | +913.6% |
| CIE | New | COBALT INTL ENERGY INC | $16,823,000 | – | 676,703 | +100.0% | 0.40% | – |
| MCK | New | MCKESSON CORP | $14,050,000 | – | 109,508 | +100.0% | 0.34% | – |
| LNKD | New | LINKEDIN CORP | $12,473,000 | – | 50,690 | +100.0% | 0.30% | – |
| HUM | New | HUMANA INC | $11,650,000 | – | 124,821 | +100.0% | 0.28% | – |
| RAD | Buy | RITE AID CORP | $8,972,000 | +207.4% | 1,884,889 | +84.7% | 0.22% | +254.1% |
| GPORQ | New | GULFPORT ENERGY CORP | $8,964,000 | – | 139,329 | +100.0% | 0.22% | – |
| MYL | New | MYLAN INC | $8,927,000 | – | 233,887 | +100.0% | 0.22% | – |
| GNMK | Buy | GENMARK DIAGNOSTICS INC | $7,891,000 | +26.2% | 650,015 | +7.6% | 0.19% | +46.2% |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $5,783,000 | – | 206,829 | +100.0% | 0.14% | – |
| BLUE | New | BLUEBIRD BIO INC | $5,335,000 | – | 197,897 | +100.0% | 0.13% | – |
| WAT | Buy | WATERS CORP | $4,573,000 | +9.2% | 43,054 | +2.9% | 0.11% | +26.4% |
| MYGN | New | MYRIAD GENETICS INC | $3,463,000 | – | 147,376 | +100.0% | 0.08% | – |
| WAT | New | WATERS CORPcall | $470,000 | – | 329,600 | +100.0% | 0.01% | – |
| RPRX | New | REPROS THERAPEUTICS INCcall | $127,000 | – | 168,800 | +100.0% | 0.00% | – |
| MYGN | New | MYRIAD GENETICS INCcall | $87,000 | – | 194,000 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2014-02-21
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 41 | Q3 2023 | 2.2% |
| HCA HOLDINGS INC | 38 | Q3 2023 | 5.2% |
| HUMANA INC | 37 | Q3 2023 | 3.8% |
| EDWARDS LIFESCIENCES CORP | 36 | Q3 2023 | 3.3% |
| UNITEDHEALTH GROUP INC | 33 | Q3 2023 | 4.8% |
| PENUMBRA INC | 33 | Q3 2023 | 4.8% |
| AERIE PHARMACEUTICALS INC | 28 | Q2 2022 | 3.7% |
| TENET HEALTHCARE CORP | 27 | Q3 2023 | 2.3% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 4.2% |
| ICON PLC | 26 | Q3 2023 | 2.5% |
View PFM Health Sciences, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adaptimmune Therapeutics PLC | February 14, 2023 | ? | ? |
| Arcus Biosciences, Inc. | February 14, 2023 | ? | ? |
| Axsome Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Erasca, Inc. | February 14, 2023 | ? | ? |
| Generation Bio Co. | February 14, 2023 | ? | ? |
| IO Biotech, Inc. | February 14, 2023 | ? | ? |
| Jounce Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Outset Medical, Inc. | February 14, 2023 | ? | ? |
| uniQure N.V. | February 14, 2023 | ? | ? |
| AERIE PHARMACEUTICALS INC | February 14, 2022 | ? | ? |
View PFM Health Sciences, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
View PFM Health Sciences, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.